Dr Akhil Kapoor

Dr Akhil Kapoor

Dr. Akhil Kapoor, a renowned Medical Oncologist, brings 5 years of expertise from Tata Memorial Hospital, Mumbai. He serves on the Molecular Tumor Board and Rare Tumor Board. His passion for clinical research and dedication to advancing oncology patient care are evident through his active involvement in cutting-edge treatments and therapies. Dr. Kapoor’s membership in specialized tumor boards reflects his commitment to multidisciplinary collaboration for improved patient outcomes.

Specializations

Dr. Akhil Kapoor performs major interventions in the following specialties –

• Lung cancer
• Urology
• Breast Cancer
• Gynecologic Cancer
• Gastrointestinal Cancer

Education & Training

• Acharya Tulsi Regional Cancer Treatment and Research Institute (MD Internal Medicine), 2012 – 2015
• North Bengal Medical College (MBBS), 2006 – 2012
• Homi Bhabha National Institute (DM Oncology)
• North Bengal Medical College, Darjeeling (MBBS)
• Sardar Patel Medical College, Bikaner (MD)

Careers

• Assistant Professor – Tata Memorial Cancer Hospital, Mumbai, 2022 – 2023
• Associate Professor – Tata Memorial Centre, Varanasi, 2020 – 2023, Varanasi
• Consultant – Acharya Tulsi Regional Cancer Institute And Research Centre, Bikaner

Treatments

Dr. Akhil Kapoor specializes in the following treatments –

• Chemotherapy
• Medical Oncology

Memberships

• Immuno Oncology Society of India (IOSOI)
• Indian Society of Medical and Pediatric Oncology (ISMPO)

Publications

Dr. Akhil Kapoor has more than 200 National and International papers and Publications. Some of them are mentioned below –

Exploring the role of systemic therapy in adult adrenocortical carcinoma: A single-center experience

Authors’ reply to Vora et al. and Singh et al.

Initial experience of a geriatric oncology clinic in a tertiary cancer center in India

Demography and pattern of care of patients with head-and-neck carcinoma: Experience from a tertiary care center in North India

Authors’ reply to Chandrasekharan et al. and Abbas

The efficacy and safety of first-line therapy for the epidermal growth factor receptor mutant non-small cell lung cancer in older versus younger patients: A pooled analysis of two randomized controlled trials

Authors’ reply to Batra et al., Chadha et al., and Deb et al.

Author’s reply to Tripathi et al. and Memon et al.

Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX

Head-and-neck dermatofibrosarcoma protuberans: Scooping out data even in dearth of evidence

Systemic chemotherapy and short‑course radiation in metastatic rectal cancers: A feasible paradigm in unresectable and potentially resectable cancers

Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with solid neoplasms: A real-world experience from a tertiary cancer center

Dr. Akhil Kapoor dedicates himself to assisting cancer patients in need, providing compassionate care and support throughout their journey. With his expertise in medical oncology and commitment to advancing treatment options, he strives to improve the lives of those affected by cancer. Dr. Kapoor’s empathetic approach and comprehensive care ensure that patients receive personalized attention and guidance tailored to their unique needs.